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Abstract
Background: The aim of the study was to determine whether the baseline heart rate (HR)
and changes in HR after mental stress (MS) can influence endothelial function in syndrome X.
Methods: Forty four patients with syndrome X (F/M: 21/23, mean age: 55.4 – 10.7 years)
were examined. The endothelium-dependent flow-mediated dilation (FMD) was defined as the
percentage change in the brachial artery diameter during reactive hyperaemia related to base-
line (%FMD). The %FMD was assessed before and after (at 10, 30, and 45 min) standardised
three-minute MS. HR and blood pressure were monitored simultaneously. The %FMD values
were compared between subgroups characterised by baseline HR, maximum HR and DHR,
and HR after MS below and over the median values.
Results: The values of %FMD measured at 10, 30 and 45 min after MS (4.39 – 5.4%,
4.99 – 3.9%, 4.03 – 3.5%, respectively; p < 0.001) were significantly lower than baseline values
(7.73 – 4.9%). Impaired vasodilatation after MS was observed in the following subgroups of
patients: those with baseline HR below the median (< 71.5 bpm; baseline: 8.35 –
– 5.8%; 10 min: 2.87 – 3.6%, 45 min: 4.56 – 3.9%; p < 0.001); those with HR after MS
below the median (< 76.5 bpm; baseline: 8.19 – 5.5; 10 min: 3.88 – 4.3%, 45 min: 4.59 –
– 3.7%; p < 0.01); and those with maximum HR after MS below the median (< 84 bpm;
baseline: 8.88 – 5.6%; 10 min: 3.88 – 3.8%, 30 min: 5.88 – 3.9%, 45 min: 4.51 – 3.8; p < 0.01).
Conclusion: The stress-induced endothelial dysfunction syndrome X is related to the baseline
HR and the changes in HR after MS, suggesting that the autonomic nervous system plays
a part in its pathogenesis. (Cardiol J 2007; 14: 180185)
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Introduction
The term cardiac syndrome X was first used
in 1973, when Kemp et al. [1] reported on normal
coronarography results (normal arteriograms) in
patients with symptoms of angina pectoris.
Endothelial dysfunction has been mentioned as
a potential cause, resulting in the compromise of
the coronary microcirculation and disturbance in
sympathetic-parasympathetic control [25].
Mental stress (MS) is a well-recognised factor
in the increase of sympathetic activation, which in
turn affects the systemic circulation, increasing the
heart rate (HR) and elevating arterial pressure,
which potentially leads to myocardial ischaemia.
Data in the literature suggest that stress may
181
Magdalena Mizia et al., Mental stress, heart rate and endothelial function
www.cardiologyjournal.org
produce angina-like pain in syndrome X patients;
thus, apart from haemodynamic changes, endothe-
lial dysfunction should also be considered in its
pathogenesis [4, 6, 7]. It is still unknown whether
stress-induced haemodynamic changes may be as-
sociated with endothelial function.
The purpose of our study was to investigate
whether baseline HR and HR increase induced by
standardised MS affects endothelial function as re-




A total of 44 patients (23 men and 21 women
with a mean age of 55.4 – 10.7 years and ranging
in age from 38 to 76 years) with cardiac syndrome
X were included in the study. The inclusion crite-
ria were typical symptoms of ischaemic heart dis-
ease, an exercise ECG showing a positive result and
absence of any lesions within the coronary vessels
on coronary arteriography.
Subgroups were defined on the basis of medi-
an values calculated for the following parameters:
baseline HR (subgroups: A1 and A2), post-MS HR
(subgroups: B1 and B2) and maximum HR (sub-
groups: C1 and C2). The parameter values in par-
ticular subgroups were lower or higher than the
median value (Table 1).
Patients with concomitant inflammatory con-
ditions, neoplastic disease, uncompensated meta-
bolic disturbances, renal or liver failure, a history
of acute coronary events, those who had undergone
surgery within the 6 months preceding the study
and those with difficult baseline ECG interpretation
were excluded. Investigations were performed in
the morning with the patients fasting and after at
least twelve hours abstinence from smoking. The
study protocol was approved by the Bioethics Com-
mittee of the Medical University of Silesia.
Evaluation of clinical parameters
The clinical parameters were evaluated together
with the results of the patients lipid profiles (total
serum cholesterol, serum HDL cholesterol, LDL
cholesterol, and triglycerides), ECG, exercise test,
echocardiography and coronarography. Patient his-
tories of smoking, concomitant disease and phar-
macotherapy used were also taken.
Mental stress
Prior to MS testing the patients were allowed
to rest in a quiet room for 15 minutes. After base-
line arterial blood pressure and HR had been re-
corded an arithmetic stress test was applied. The
subjects were required to listen to a recorded mes-
sage instructing patients how to perform the men-
tal stress task. They were asked to subtract 7 re-
peatedly from 777 and the consecutive results of
subtraction for 3 min. Arterial pressure and HR
were measured during and following the MS. None
of the investigators had any communication with
the subjects during this time. The subjects were
asked to fill in a psychological questionnaire grad-
ing emotional tension before and after the MS on
scale of 1 to 4.
Flow-mediated dilation
Flow-mediated dilation (FMD) was measured
before MS, and at 10, 30, and 45 min afterwards.
Each time a dedicated and specifically trained in-
vestigator took measurements using a high-fre-
quency ultrasound system in B-mode presentation.
During image acquisition anatomical landmarks,
including veins and facial planes, and a stereotactic
clamp were useful for maintaining the same image
of the artery throughout the study.
The baseline brachial artery diameter was de-
termined. Subsequently a three-minute vessel oc-
clusion was produced by inflating a manometer cuff
up to over 200 mm Hg or a value equal to systolic
pressure of + 50 mm Hg. Within 60 s of cuff defla-
tion several measurements of the vessel diameter
were taken. The percentage change in the diame-
ter was calculated (%FMD). After 15 minutes vas-
cular response to sublingual nitroglycerine (0.4 mg)
was assessed on the basis of %NTG-MD (%NTG
 mediated dilatation) [8].
Table 1. Division of study group into subgroups.
Division criteria Study subgroups
Baseline heart rate A1  below median value
(median 71.5) (N = 22)
A2  above median value
(N = 22)
Post-mental stress B1  below median value
heart rate (N = 22)
(median 76.5) B2  above median value
(N  = 22)
Maximum heart C1  below median value
rate (median 84) (N = 24)
C2  above median value
(N = 20)
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Statistical analysis
The results were analysed statistically. Medi-
an values were calculated for the following param-
eters: baseline HR, post-MS HR and maximum HR.
See above under study population for the sub-
group division. Means and standard deviations were
calculated for all the subjects and the subgroups
examined. Clinical parameters and the results of
accessory investigations were compared using the
c2 test for proportions and the two-sample t-tests
for normally distributed continuous variables; in the
case of abnormal distribution the Mann-Whitney U
test was used. Values of p < 0.05 were considered
to indicate statistical significance.
Results
The characteristics of the study group are present-
ed in Table 2. The subgroups (delineated in Table 1)
were similar regarding sex, age and incidence of
arterial hypertension. Comparison of clinical data
between subgroups revealed the following differ-
ences: subgroups A1 vs. A2  difference in se-
rum triglyceride concentrations (114.4 – 43.6 vs.
178.9 – 81.1; p = 0.005); subgroups B1 vs. B2 
differences in left ventricular mass index (150.3 –
– 29.9 vs. 127.1 – 24.5; p = 0.02) and in Ca-block-
er use (40.1% vs. 9.1%; p = 0.005). No significant
differences were found between the clinical pa-
rameters assessed in the subgroups C1 and C2.
The assessment of emotional tension question-
naires on a scale of 1 to 4 showed a significant in-
crease in the parameter from baseline: 1.77 – 1.12,
to 2.34 – 1.1; p < 0.05 after the MS. The increase
was comparable in the subgroups studied. The re-
sults of arterial pressure and HR recordings dur-
ing MS are presented in Table 3.
As shown in Figure 1, a reduction in %FMD
was observed in all study subjects at 10, 30, and
45 min following MS (4.39 – 5.4%, 4.99 – 3.9%,
4.03 – 3.5%, respectively; p < 0.001) as compared
to the baseline (7.73 – 4.9%).
Comparison of the results between subgroups
revealed a significant %FMD decrease at 10, and
45 min in subgroups A1, and B1. The mean %FMD
values were as follows: subgroup A1 (Fig. 2):
2.87 – 3.6% at 10 min, 4.56 – 3.9% at 45 min,Table 2. Characteristics of study group.
N 44
Age (years) 55.4–10.7
Body mass index [kg/m2] 29.5–3.9
Total cholesterol [mg/dl] 220.0–46.1
HDL cholesterol [mg/dl] 49.5–15.4
LDL cholesterol [mg/dl] 140.7–40.6
Triglycerides [mg/dl] 146.7–72.1
Left ventricular mass [g] 266.9–66.4
Left ventricular mass index [g/m2] 138.9–29.5
Ejection fraction (%) 58.0–7.6
Smoking status:
active smoker 5 (11.4%)
ex-smoker 3 (29.5%)
never smoked 25 (56.8%)
Pharmacotherapy:
ACE inhibitors 25 (56.8%)
Ca-blockers 11 (25%)
Statins 21 (47.7%)
ACE inhibitors: peridopril, quinalapril, enalapril; Ca-blockers: amlodipine,
diltiazem; statins: atorwastatin, simvastatin, lovastatin
Table 3. Arterial blood pressure, heart rate before and after mental stress (MS).
Before MS After MS Maximum values D (increase)
Systolic blood pressure [mm Hg] 127.4–14.6 144.1–20.1  21.5–15
Diastolic blood pressure [mm Hg]) 77.7–9.9 87.2–13.2  13.3–8.3
Heart rate [bpm] 71.2–12.7 78.3–16.9 86.5–20.4 8–7.3
Figure 1. Flow mediated dilatation (%) measured at 10,
30 and 45 minutes after mental stress (MS) in study
group; *p < 0.001 (vs. baseline values).
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baseline: 7.11 – 3.9% (Fig. 2); subgroup B2: 3.82 –
– 4.1%, and 3.46 – 3.3% at 30 and 45 min, respec-
tively (p < 0.01); baseline: 7.27 – 4.4% (Fig. 3);
subgroup C2: 3.88 – 3.6%, and 3.43 – 3.0% at 30
and 45 min respectively (p < 0.01); baseline: 6.35 –
– 3.6% (Fig. 4).
Discussion
The purpose of our study was to investigate
whether HR increase induced by standardised MS
affected endothelial function in patients with cardi-
ac syndrome X. Endogenous vasodilatory response
was indicated by FMD, a marker of endothelium-
mediated dilation.
Reduction of %FMD was observed in all
study subjects at 10, 30, and 45 min following MS.
Thus endothelial dysfunction was noted, lasting
for at least 45 min following three-minute stand-
ardised MS.
Subgroup analysis revealed a relationship be-
tween HR and early and late endothelial dysfunction
after MS. Early dysfunction, at 10 min following MS,
was observed in patients with a lower baseline HR.
In those with a high baseline HR the mental stres-
sor elicited compromised vasodilatory responses
only at 30 and 45 min. It is important that the above-
mentioned changes were observed despite a com-
parable increase in emotional tension after MS.
Literature data on the effect of MS on endothe-
lial function are somewhat scarce. Those available
are mostly related to animal studies and there are
Figure 4.  Flow mediated dilatation (%) in subgroups C1
and C2 (maximum heart rate below and above median
values); *p < 0.02 (vs. baseline values); **p < 0.05
(vs. baseline values).
Figure 2. Flow mediated dilatation (%) in subgroups A1
and A2 (baseline heart rate below and above median
values); *p < 0.001 (vs. baseline values); **p < 0.02
(vs. baseline values).
Figure 3.  Flow mediated dilatation (%) in subgroups B1
and B2 (post-mental stress heart rate below and above
median values); *p < 0.01 (vs. baseline values); **p < 0.001
(vs. baseline values).
8.35 – 5.8% at baseline (p < 0.001); subgroup B1
(Fig. 3): 3.88 – 4.3% at 10 min, 4.59 – 3.7% at 45 min,
8.19 – 5.5% at baseline (p < 0.01). In subgroup C1
(Fig. 4) %FMD was reduced at 10, 30, and 45 min
after MS to 3.88 – 3.8%, 5.88 – 3.9%, and 4.51 –
– 3.8% respectively; baseline: 8.88 – 5.6%.
In  subgroups A2, B2 and C2 significant %FMD
reduction was noted only at 30 and 45 min after
MS: subgroup A2: 3.33 – 3.8%, and 3.48 – 3%
at 30 and 45 min, respectively (p < 0.001);
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few reports on the phenomenon in healthy volunteers
and patients with coronary artery disease [913]. In
animals prolonged stress caused endothelial dys-
function by increasing the number of damaged cells
and compromising nitric oxide availability in the
vascular wall [14].
In a healthy population MS induced an eleva-
tion of arterial pressure, an increase in HR and
a decrease in brachial artery diameter. The values
of %FMD were significantly attenuated at 30 and
90 min after MS and only normalised after four
hours of observation [15]. In our group endothelial
dysfunction was still seen at 45 min after MS;
a study of longer duration would allow us to estab-
lish the time point at which %FMD normalises.
It is also significant that stress reduces both
peripheral and coronary flow. Kop et al. [16] used
a similar arithmetic stress test in patients with co-
ronary artery disease and demonstrated coronary
vasospasm in as many as 19% of the population. The
elevation of arterial pressure observed correlated
with a reduced diameter of atherosclerotic seg-
ments, while the diameter of the normal artery re-
mained unchanged.
There is an even greater scarcity of reports on
the relationship between endothelial and autonomic
functions. Some indirect conclusions may, however, be
drawn from reports on the relationship between sympa-
thetic activation and ambulatory ischaemic events [17].
It has been shown that ischaemic events associated
with high emotional stress have been preceded by
a lowered HF-HRV component, still observed 20 min
after ECG normalisation. This might suggest that
stress causes prolonged disturbances of the auto-
nomic balance. However, the results were obtained
for patients with coronary artery disease; similar data
on cardiac X syndrome are lacking.
Spieker et al. [18] confirmed that MS induces
endothelial dysfunction but did not demonstrate any
correlation between %FMD, arterial pressure and
HR changes during MS. The authors suggest that
endothelial dysfunction may be associated with
endothelin activation. Administration of an endothe-
lin type A receptor-selective antagonist prevented
the development of endothelial dysfunction and
%FMD approximated to baseline values as early as
10 min following MS. Intravascular norepinephrine
with a similar duration to the MS caused only tran-
sient vasoconstriction.
The Framingham Heart Study on a sub-popula-
tion of 3500 [19] demonstrated a positive correlation
between %FMD, female subjects, physical exercise
(the walk test) and, significantly from our point
of view, HR. Subsequent investigation [20] showed
that patients with an impaired chronotropic re-
sponse to the graded exercise test had endothelial
dysfunction and enhanced systemic inflammation.
Animal studies [14] as well as our previous
results [21] suggest that a higher-frequency pulsate
flow is associated with increased nitric oxide re-
lease. In subjects with physical exercise applied
before %FMD evaluation the mechanism undoubt-
edly affected the ultimate results. However, an anal-
ysis carried out for a subgroup not involved in the
walk test demonstrated that HR-FMD was unre-
lated to physical effort.
Absence of a defence mechanism in the form
of a higher HR increases the risk of early endothe-
lial dysfunction after MS. HR elevation, possibly
resulting from enhanced stimulation of nitric oxide
synthesis, prevents the development of early dys-
function.
Studies on patients with metabolic syndrome
yielded different results. A negative correlation was
found between %FMD and HR [22]. The relation-
ship between endothelial function and autonomic
activation thus requires further investigation.
In summary, MS induces endothelial dysfunc-
tion in patients with cardiac X syndrome. Lower
baseline and post-MS HR seem to promote early
dysfunction. Although controversial, support is lent
to the observation by the results of laboratory and
clinical studies.
Since HR elevation increases oxygen demand,
it can be concluded that bradycardia and tachycar-
dia resulting from stress may induce heart ischae-
mia through two completely different mechanisms.
None of our patients had symptomatic ischae-
mia as a result of the mental stressor applied. Thus
it would be difficult to speculate on the practical
aspect of our observations. It should be emphasised,
however, that %FMD remains one of the best mark-
ers of the risk for cardiovascular events, accurately
reflecting the function of the endothelium. Attenuation
of %FMD increases the risk of cardiovascular events.
Prolonged post-MS %FMD depression constitutes an
immediate threat to the patients condition.
In conclusion, in patients with cardiac X syn-
drome mental stress induces endothelial dysfunction
that is related to baseline and post-mental stress
heart rates. This emphasises the role of the autonom-
ic nervous system in the pathogenesis of the dys-
function. Lower baseline and post-mental stress heart
rates seem to promote early endothelial dysfunction.
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